You are here: Home » Current Affairs » News » Health
Business Standard

Wockhardt gets USFDA nod for generic eye drops

The product will be manufactured at a USFDA approved contract manufacturing organisation

Press Trust of India  |  New Delhi 

medicine, drug, drugs, tablets
Photo: Shutterstock

Drug firm has received approval from the US regulator for generic Olopatadine HCl eye drops used for the treatment of opthalmic allergies.

The company has received final approval from the United States Food and Drug Administration (USFDA) for Olopatadine HCl 0.1 per cent opthalmic solution, said in a filing today.

The product is a generic version of Patanol, which is marketed in the US by Alcon, a subsidiary of pharma major Novartis, it added.

The product will be manufactured at a approved contract manufacturing organisation based in Montreal, Canada, said.

of Wockhardt today closed 0.18 per cent higher at Rs 605.05 per scrip on

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Mon, July 03 2017. 17:07 IST